Please check your internet connection and try again.
# Megacv Duo (Amoxicillin/Clavulanate)
## Overview
Megacv Duo is a fixed-dose combination antibiotic containing the beta-lactam amoxicillin and the beta-lactamase inhibitor clavulanate potassium (often in a 7:1 or similar "high-ratio" formulation). The clavulanate component extends the spectrum of activity to include beta-lactamase-producing organisms.
## Primary Indications
* Community-acquired pneumonia
* Acute bacterial sinusitis
* Acute otitis media
* Skin and skin structure infections
* Urinary tract infections (when susceptible)
## Adult Dosing
* **Standard dose:** 875 mg amoxicillin / 125 mg clavulanate orally every 12 hours.
* **Severe infections:** 875 mg amoxicillin / 125 mg clavulanate every 8 hours (check local availability).
* *Note: Dosing is typically based on the amoxicillin component.*
## Pediatric Dosing
* **General recommendation:** 45 mg/kg/day to 90 mg/kg/day (based on amoxicillin component) divided every 12 hours.
* **Acute Otitis Media:** Highly variable dosing depending on local resistance patterns; 90 mg/kg/day is common for high-risk patients.
* **Maximum:** Do not exceed adult doses.
## Dose Adjustments
* **Renal Impairment (CrCl < 30 mL/min):** Avoid sustained-release or high-strength tablets (875 mg formulations). Use dosage forms with lower clavulanate content and adjust the frequency of the amoxicillin component.
* **Hepatic Impairment:** Use with caution; monitor liver function regularly.
## Contraindications
* History of amoxicillin-associated cholestatic jaundice or hepatic dysfunction.
* Severe hypersensitivity to penicillins or any cephalosporin (history of anaphylaxis).
* Known hypersensitivity to clavulanate.
## Adverse Effects
* **Gastrointestinal:** Diarrhea (very common), nausea, vomiting, abdominal pain.
* **Hepatic:** Elevated LFTs, hepatitis, cholestatic jaundice (more common in males > 60 years or with prolonged therapy).
* **Dermatologic:** Rash (maculopapular), urticaria.
* **Other:** Candidiasis (superinfection).
## Key Drug Interactions
* **Methotrexate:** Amoxicillin may decrease renal clearance of methotrexate, increasing toxicity risk.
* **Warfarin:** Prolonged prothrombin time (INR) has been reported; monitor INR closely during initiation.
* **Oral Contraceptives:** Potential for decreased efficacy (counsel regarding backup methods).
* **Probenecid:** Decreases renal excretion of amoxicillin, increasing serum levels.
## Monitoring
* **Renal:** Periodic monitoring of BUN and Serum Creatinine in patients with pre-existing renal impairment.
* **Hepatic:** ALT/AST and bilirubin at baseline and periodically with prolonged therapy (if > 14 days).
* **Hematologic:** Monitor for signs of hypersensitivity or superinfection.
## Clinical Pearls
* **Administration:** Administer at the start of a meal to minimize gastrointestinal upset and ensure better absorption of the clavulanate component.
* **Resistance:** Not effective against MRSA or organisms producing extended-spectrum beta-lactamases (ESBLs).
* **Ratio Matters:** Ensure the correct ratio is selected; formulations are not always interchangeable MG-for-MG due to differing amounts of the beta-lactamase inhibitor. Always verify local hospital/regional antibiograms for empiric use.
***
**Educational Disclaimer:** This information is for educational purposes only. Always verify dose, contraindications, and drug interactions against the most current manufacturers' prescribing information or institutional protocols before prescribing or administering medication.
